-
Witnessed trauma exposure induces fear in mice through a reduction in endogenous neurosteroid synthesis J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-03-14 Aidan Evans‐Strong, Najah Walton, Katrina Blandino, Abigail T. C. Roper, S. Tiffany Donaldson, Mike Lewis, Jamie Maguire
-
Neuroendocrine neoplasms: Consensus on a patient care pathway J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-03-12 Jessica Hooper, Nikie Jervis, Lucy Morgan, Vivienne Beckett, Philippa Hand, Kate Higgs, Alia Munir, Jenny Prinn, D Mark Pritchard, Debashis Sarker, Raj Srirajaskanthan, Catherine Bouvier Ellis
People with neuroendocrine neoplasms (NENs) face a multitude of challenges, including delayed diagnosis, low awareness of the cancer among healthcare professionals and limited access to multidisciplinary care and expert centres. We have developed the first patient care pathway for people living with NENs in England to guide disease management and help overcome these barriers. The pathway was developed
-
-
Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-03-13 Dimitrios Papantoniou, Katarzyna Fröss‐Baron, Ulrike Garske‐Román, Anders Sundin, Espen Thiis‐Evensen, Malin Grönberg, Staffan Welin, Eva Tiensuu Janson
-
The olfactory bulb: A neuroendocrine spotlight on feeding and metabolism J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-03-12 Romana Stark
-
Prognostic value of inflammation‐related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta‐analysis J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-03-12 Ling‐Jun Cui, Fu‐Huan Yu, Zi‐Xuan Cheng, Fei Su, Ying‐Ying Chen, Huang‐Ying Tan
-
Constitutive cell proliferation and neurogenesis in the organum vasculosum lamina terminalis and subfornical organ of adult rats J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-02-28 Suijian Zhou, Olena Makashova, Pierre-Marie Chevillard, Vanessa Josey, Banruo Li, Masha Prager-Khoutorsky
-
Kisspeptin and neurokinin B neuroendocrine pathways in the control of human ovulation J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-02-26 Richard A. Anderson
-
Development and prenatal exposure to androgens alter potassium currents in gonadotropin-releasing hormone neurons from female mice J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-02-25 Jennifer Jaime, R. Anthony DeFazio, Suzanne M. Moenter
-
The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-02-23 Dominique S. V. M. Clement, Monique E. van Leerdam, Margot E. T. Tesselaar, Elmie Cananea, Wendy Martin, Martin O. Weickert, Debashis Sarker, John K. Ramage, Rajaventhan Srirajaskanthan
Patients with neuroendocrine tumours located in the gastroenteropancreatic tract (GEP‐NETs) and treatment with somatostatin analogues (SSA's) are at risk of malnutrition which has been reported previously evaluating weight loss or body mass index (BMI) only. The global leadership into malnutrition (GLIM) criteria include weight loss, BMI, and sarcopenia, for diagnosing malnutrition. These GLIM criteria
-
Vernal growth of vocal control nucleus Area X, but not HVC, precedes gonadal recrudescence in wild black‐capped chickadees (Poecile atricapillus) J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-02-21 Broderick M. B. Parks, Kyle McVea, Leslie S. Phillmore
-
Plasma tryptophan pathway metabolites quantified by liquid chromatography-tandem mass spectrometry as biomarkers in neuroendocrine tumor patients J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-02-15 S. U. Johansen, T. Hansen, A. Nordborg, R. Meyer, R. Goll, J. Florholmen, E. Jensen
-
Opposing effects of thyroid hormones on hypothalamic subunits and limbic structures in hyperthyroidism patients: A comprehensive volumetric study J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-02-07 Barış Genç, Kerim Aslan, Uğur Avcı, Lütfi İncesu, Hediye Pınar Günbey
Thyroid hormones play a critical role in brain development, but paradoxically, patients with hyperthyroidism often exhibit cognitive decline and irritability. This study aims to explore the pattern of atrophy in hyperthyroid patients, changes in specific areas of the brain, including hypothalamic subfields and limbic structures, and their relationships with hormonal levels and psychometric tests. This
-
Androgen receptor actions on AgRP neurons are not a major cause of reproductive and metabolic impairments in peripubertally androgenized mice J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-02-12 Romy I. Kerbus, Caroline Decourt, Megan A. Inglis, Rebecca E. Campbell, Greg M. Anderson
-
Correction to Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumours and differentiation from small intestinal neuroendocrine tumours. J Neuroendocrinol. 2022 Jul;34(7):e13176. J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-01-29
Espen Thiis-Evensen1, Magnus Kjellman2, Ulrich Knigge3, Henning Gronbaek4, Camilla Schalin-Jäntti5, Staffan Welin6, Halfdan Sorbye7, Maria del Pilar Schneider8 and Roger Belusa9 on behalf of The Nordic NET Biomarker Group Due to the use of a wrong version of the informed consent form four patients have to be excluded from the analyses. This has unfortunately led to other results than previously published
-
An integrated single-cell RNA-seq atlas of the mouse hypothalamic paraventricular nucleus links transcriptomic and functional types J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-01-28 J. B. Berkhout, D. Poormoghadam, C. Yi, A. Kalsbeek, O. C. Meijer, A. Mahfouz
-
The temporal and spatial pattern of leptin receptor-expressing cells in the developing mouse hypothalamus J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-01-27 Matt B. A. Higgins, Kelly A. Glendining, Christine L. Jasoni
The arcuate nucleus is a crucial hypothalamic brain region involved in regulating body weight homeostasis. Neurons within the arcuate nucleus respond to peripheral metabolic signals, such as leptin, and relay these signals via neuronal projections to brain regions both within and outside the hypothalamus, ultimately causing changes in an animal's behaviour and physiology. There is a substantial amount
-
Mesenteric fibrosis in patients with small intestinal neuroendocrine tumors is associated with enrichment of alpha-smooth muscle actin-positive fibrosis and COMP-expressing stromal cells J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-01-21 Sebastian D. Graf, Corinna U. Keber, Akira Hattesohl, Julia Teply-Szymanski, Sophia Hattesohl, Marc Guder, Norman Gercke, Pietro Di Fazio, Emily P. Slater, Moritz Jesinghaus, Carsten Denkert, Detlef K. Bartsch, Bettina Lehman
-
Early corticosterone increases vocal complexity in a wild parrot: An organizational role of the hypothalamic–pituitary–adrenal axis in vocal learning? J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-01-10 Celia R. McLean, Astolfo Mata, Richard J. Kline, Karl S. Berg
-
Male rat hypothalamic extraretinal photoreceptor Opsin3 is sensitive to osmotic stimuli and light J. Neuroendocrinol. (IF 3.2) Pub Date : 2024-01-09 Soledad Bárez-López, Paul Bishop, Daniel Searby, David Murphy, Michael P. Greenwood
The light-sensitive protein Opsin 3 (Opn3) is present throughout the mammalian brain; however, the role of Opn3 in this organ remains unknown. Since Opn3 encoded mRNA is modulated in the supraoptic and paraventricular nucleus of the hypothalamus in response to osmotic stimuli, we have explored by in situ hybridization the expression of Opn3 in these nuclei. We have demonstrated that Opn3 is present
-
Effects of metformin on behavioral alterations produced by chronic sucrose consumption in male rats J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-12-26 Mariana Rey, Héctor Coirini, Agustina Marchena, María Claudia González Deniselle, María Sol Kruse
-
Use and perceived utility of [18F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022 J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-12-14 Valentina Ambrosini, Martyn Caplin, Justo P. Castaño, Emanuel Christ, Timm Denecke, Christophe M. Deroose, Clarisse Dromain, Massimo Falconi, Simona Grozinsky-Glasberg, Rodney J. Hicks, Johannes Hofland, Andreas Kjaer, Ulrich Peter Knigge, Beata Kos-Kudla, Anna Koumarianou, Balkundi Krishna, Angela Lamarca, Marianne Pavel, Nicholas Simon Reed, Aldo Scarpa, Rajaventhan Srirajaskanthan, Anders Sundin
-
Correction to “Efficacy, safety and unmet needs of evolving medical treatments for carcinoid syndrome” J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-12-13
Koumarianou, A, Daskalakis, K, Tsoli, M, Kaltsas, G, Pavel, M. Efficacy, safety and unmet needs of evolving medical treatments for carcinoid syndrome. J Neuroendocrinol. 2022; 34(7):e13174. doi:10.1111/jne.13174 An oversight has occurred in the published version of our paper “Efficacy, safety and unmet needs of evolving medical treatments for carcinoid syndrome”. Upon review, we have discovered in
-
Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-12-13 Tharani Krishnan, Maria Safro, Daniel Moreira Furlanetto, Sharlene Gill, Joao Paulo Solar Vasconcelos, Heather C. Stuart, Patrick Martineau, Jonathan M. Loree
-
Preconceptional and in utero exposure of sheep to a real-life environmental chemical mixture disrupts key markers of energy metabolism in male offspring J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-12-12 Mohammad Ghasemzadeh-Hasankolaei, Chris S. Elcombe, Samantha Powls, Richard G. Lea, Kevin D. Sinclair, Vasantha Padmanabhan, Neil P. Evans, Michelle Bellingham
-
Dynamic, sex- and diet-specific pleiotropism in the PAC1 receptor-mediated regulation of arcuate proopiomelanocortin and Neuropeptide Y/Agouti related peptide neuronal excitability by anorexigenic ventromedial nucleus PACAP neurons J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-12-06 Veronica Mata-Pacheco, Jennifer Hernandez, Nandini Varma, Jenny Xu, Sarah Sayers, Nikki Le, Edward J. Wagner
-
Peptide receptor chemoradionuclide therapy for neuroendocrine neoplasms: A systematic review J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-11-21 Dennis S. Chan, Aran L. Kanagaratnam, Nick Pavlakis, David L. Chan
-
Alzheimer's disease-related brain insulin resistance and the prospective therapeutic impact of metformin J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-11-20 Hamed A. Abosharaf, Yasmin Elsonbaty, Ehab Tousson, Tarek M. Mohamed
-
Gene deletion of the PACAP/VIP receptor, VPAC2R, alters glycemic responses during metabolic and psychogenic stress in adult female mice J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-11-10 Elena V. Kozlova, Anthony E. Bishay, Maximilian E. Denys, Bhuvaneswari D. Chinthirla, Matthew C. Valdez, Kurt A. Spurgin, Julia M. Krum, Karthik R. Basappa, Margarita C. Currás-Collazo
-
High fat diet-induced maternal obesity in mice impairs peripartum maternal behaviour J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-11-05 Rosemary Shanon Eileen Brown, Ireland M. Jacobs, Zin Khant Aung, Pene J. Knowles, David R. Grattan, Sharon R. Ladyman
-
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral center J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-11-02 Valentina Andreasi, Stefano Partelli, Francesca Muffatti, Anna Battistella, Francesca Fermi, Gianpaolo Balzano, Stefano Crippa, Domenico Tamburrino, Nicolò Pecorelli, Francesco De Cobelli, Paolo Giorgio Arcidiacono, Massimo Falconi
-
Dual action of serotonin on local excitatory and inhibitory neural circuits regulating the corticotropin-releasing factor neurons in the paraventricular nucleus of the hypothalamus J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-10-30 Takayuki Sato, Takuma Sugaya, Ashraf Hossain Talukder, Yuki Tsushima, Shotaro Sasaki, Katsuya Uchida, Tatsuya Sato, Yoko Ikoma, Kenji Sakimura, Atsuo Fukuda, Ko Matsui, Keiichi Itoi
-
Reduction of body weight by increased loading is associated with activation of norepinephrine neurones in the medial nucleus of the solitary tract J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-10-26 Jovana Zlatkovic, Adrià Dalmau Gasull, Daniel Hägg, Ferran Font-Gironès, Jakob Bellman, Björn Meister, Vilborg Palsdottir, Johan Ruud, Claes Ohlsson, Suzanne L. Dickson, Fredrik Anesten, John-Olov Jansson
-
Advances in peptide modulation in systems physiology. J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-10-15 Lee E Eiden,David Grattan,Xiao-Dong Wang,Limei Zhang
-
Safety and efficacy of peptide receptor radionuclide therapy in patients with advanced pheochromocytoma and paraganglioma: A single-institution experience and review of the literature J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-10-12 Charlene Yu Lin Tang, Wei Ming Chua, Hian Liang Huang, Winnie Wing-Chuen Lam, Lih Ming Loh, David Tai, Simon Yew Kuang Ong, Sean Xuexian Yan, Kelvin S. H. Loke, David Chee-Eng Ng, Wei Ying Tham
-
The role of maternal hormones in regulating autonomic functions during pregnancy J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-10-11 T. Georgescu
-
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-10-05 Beata Kos-Kudła, Justo P. Castaño, Timm Denecke, Enrique Grande, Andreas Kjaer, Anna Koumarianou, Louis de Mestier, Stefano Partelli, Aurel Perren, Stefan Stättner, Juan W. Valle, Nicola Fazio
This ENETS guidance paper for well-differentiated nonfunctioning pancreatic neuroendocrine tumours (NF-Pan-NET) has been developed by a multidisciplinary working group, and provides up-to-date and practical advice on the management of these tumours. Using the extensive experience of centres treating patients with NF-Pan-NEN, the authors of this guidance paper discuss 10 troublesome questions in everyday
-
Metabolic effects of atypical antipsychotics: Molecular targets J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-10-04 Maria Fonseca, Francisca Carmo, Fátima Martel
-
Early life stress lastingly alters the function and AMPA-receptor composition of glutamatergic synapses in the hippocampus of male mice J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-10-04 Niek Brosens, Carla Simon, Helmut W. Kessels, Paul J. Lucassen, Harm J. Krugers
-
Serotonergic neurons are involved in the counter-regulatory response to hypoglycemia J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-10-03 Hugo Martin, Adeline Coursan, Justine Lallement, Mathieu Di Miceli, Janany Kandiah, Ilyès Raho, Jasmine Buttler, Jean-Philippe Guilloux, Philippe De Deurwaerdere, Sophie Layé, Vanessa H. Routh, Bruno P. Guiard, Christophe Magnan, Céline Cruciani-Guglielmacci, Xavier Fioramonti
-
Improved health-related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-09-25 Katarina Edfeldt, Per Hellman, Dan Granberg, Pernilla Lagergren, Espen Thiis-Evensen, Anders Sundin, Camilla Andersson
-
Role of membrane estrogen receptor alpha (ERα) in the rapid regulation of male sexual behavior J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-09-20 Catherine de Bournonville, Philippine Lemoine, Jean-Michel Foidart, Jean-François Arnal, Françoise Lenfant, Charlotte A. Cornil
-
Nitric oxide synthase contributes to the maintenance of LTP in the oxytocin–mRFP1 neuron of the rat hypothalamus J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-09-06 Takanori Matsuura, Makoto Kawasaki, Hitoshi Suzuki, Teruaki Fujitani, Kazuhiko Baba, Haruki Nishimura, Naofumi Ikeda, Yoshiaki Yamanaka, Manabu Tsukamoto, Yosuke Yoshimi, Hideo Ohnishi, Yoichi Ueta, Akinori Sakai
-
Intranasal oxytocin does not change partner preference in female titi monkeys (Plecturocebus cupreus), but intranasal vasopressin decreases it J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-09-01 Pauline Zablocki-Thomas, Allison Lau, Lynea Witczak, Madison Dufek, Amber Wright, Logan Savidge, John Paulus, Alexander Baxter, Chloe Karaskiewicz, Adele M. H. Seelke, Sara M. Freeman, Emilio Ferrer, Karen L. Bales
-
ICN 2022: Meeting up again and celebrating neuroendocrinology with the international community J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-08-26 Julian Mercer
CONFLICT OF INTEREST STATEMENT The author declares no conflict of interest.
-
ACTH-secreting pancreatic neuroendocrine neoplasms: A case-series J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-08-19 Taymeyah Al-Toubah, Eleonora Pelle, Julie Hallanger-Johnson, Mintallah Haider, Jonathan Strosberg
-
Sexually dimorphic oxytocin receptor-expressing (OXTR) neurons in the anteroventral periventricular nucleus (AVPV) in the postpartum female mouse are involved in maternal behavior J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-08-19 Kaustubh Sharma, Armita A. Govar, Bandana Ghimire, Katsuhiko Nishimori, Elizabeth Hammock, Ryoichi Teruyama
-
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for appendiceal neuroendocrine tumours (aNET) J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-08-16 Gregory Kaltsas, Thomas Walter, Ulrich Knigge, Christos Toumpanakis, Ana P. Santos, Nehara Begum, Ulrich F. Pape, Marco Volante, Andrea Frilling, Anne Couvelard
-
Fasting increases circulating angiotensin levels and brain Agtr1a expression in male rats J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-08-15 Bruno Paes-Leme, Lívia da Rocha Natalino Monteiro, Khadijeh Gholami, See Ziau Hoe, Alastair Victor Ferguson, David Murphy, José Antunes-Rodrigues, Rodrigo Rorato, Luis Carlos Reis, André Souza Mecawi
-
Heralding a new era of oxytocinergic research: New tools, new problems? J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-08-14 Ferdinand Althammer
-
Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-08-07 Lucie Duponchelle, Eric Baudin, Fabien Subtil, Christine Do Cao, Eric Dansin, Marine Perrier, Marie-Pierre Teissier, Magalie Haissaguerre, Xavier Cansouline, Julien Hadoux, Galina Jepiral, Catherine Lombard-Bohas, Olaf Mercier, François Tronc, Thomas Walter
-
The role of prolactin in the suppression of the response to restraint stress in the lactating mouse J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-08-03 Papillon E. Gustafson, Shahd A. Al-Isawi, Hollian R. Phillipps, Hugo W. Crosse, David R. Grattan, Stephen J. Bunn, Siew H. Yip
Suppression of the hypothalamic–pituitary–adrenal (HPA) axis is a well-characterised maternal adaptation that limits the exposure of the offspring to maternally-derived stress hormones. This current study has investigated the possible involvement of the lactogenic hormone, prolactin, in this physiologically important adaptation. As expected, circulating prolactin levels were higher in unstressed lactating
-
Clinical features and outcomes of appendiceal neuroendocrine tumours: 10 year audit from the Irish NET Centre of Excellence J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-07-31 Darragh Storan, Niall Swan, Kara Swan, Rhona Thuillier, Stephen Skehan, Tom Gallagher, Donal O'Shea, Dermot O'Toole
-
Serotonergic regulation of appetite and sodium appetite J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-07-20 Yurim Shin, Seungjik Kim, Jong-Woo Sohn
Serotonin is a neurotransmitter that is synthesized and released from the brainstem raphe nuclei to affect many brain functions. It is well known that the activity of raphe serotonergic neurons is changed in response to the changes in feeding status to regulate appetite via the serotonin receptors. Likewise, changes in volume status are known to alter the activity of raphe serotonergic neurons and
-
Dietary wheat gluten induces astro- and microgliosis in the hypothalamus of male mice J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-07-17 Mohammed Z. Rizwan, Romy Kerbus, Kaj Kamstra, Pramuk Keerthisinghe, Alexander Tups
Gluten, which is found in cereals such as wheat, rye and barley, makes up a major dietary component in most western nations, and has been shown to promote body mass gain and peripheral inflammation in mice. In the current study, we investigated the impact of gluten on central inflammation that is typically associated with diet-induced obesity. While we found no effect of gluten when added to a low-fat
-
Patent foramen ovale in carcinoid heart disease: The potential role for and risks of percutaneous closure prior to cardiothoracic surgery J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-07-17 Sasha Douglas, Tessa Oelofse, Tahir Shah, Stephen Rooney, Sayqa Arif, Richard P. Steeds
Neuroendocrine tumours (NETs) are rare but once metastasised, can lead to the release of vasoactive substances into the systemic circulation, and the classical features of carcinoid syndrome (CS) such as flushing and diarrhoea. A consequence of CS is carcinoid heart disease (CHD) which primarily affects the right-sided heart valves and can eventually lead to right heart failure. In this cohort, tricuspid
-
The role of N-terminal pro-brain natriuretic peptide, chromogranin A, and 5-hydroxyindoleacetic acid in screening for carcinoid heart disease J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-07-16 Karen Kristina Nyvold Johnson, Tobias Stemann Lau, Simon Mark Dahl Baunwall, Gerda Elisabeth Villadsen, Vibeke Guldbrand Rasmussen, Henning Grønbæk, Riina Karoliina Oksjoki, Gitte Dam
-
Neuropeptidergic control circuits in the spinal cord for male sexual behaviour: Oxytocin–gastrin-releasing peptide systems J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-07-16 Takumi Oti, Hirotaka Sakamoto
The neuropeptidergic mechanisms controlling socio-sexual behaviours consist of complex neuronal circuitry systems in widely distributed areas of the brain and spinal cord. At the organismal level, it is now becoming clear that “hormonal regulations” play an important role, in addition to the activation of neuronal circuits. The gastrin-releasing peptide (GRP) system in the lumbosacral spinal cord is
-
Imaging surveillance in multiple endocrine neoplasia type 1: Ten years of experience with somatostatin receptor positron emission tomography J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-07-08 Maha Said, Jesper Krogh, Ulla Feldt-Rasmussen, Åse Krogh Rasmussen, Thomas Skaarup Kristensen, Caroline Maria Rossing, Helle Hjorth Johannesen, Peter Oturai, Pernille Holmager, Andreas Kjaer, Marianne Klose, Seppo Langer, Ulrich Knigge, Mikkel Andreassen
Guidelines for multiple endocrine neoplasia type 1 (MEN1) recommend intensive imaging surveillance without specifying a superior regimen, including the role of somatostatin receptor imaging (SRI) with positron emission tomography (PET). The primary outcomes were to: (1) Assess change in treatment of duodenal-pancreatic neuroendocrine neoplasms (DP-NENs), bronchopulmonary NENs, and thymic tumors attributed
-
Adverse effects of gestational ω-3 and ω-6 polyunsaturated fatty acid imbalance on the programming of fetal brain development J. Neuroendocrinol. (IF 3.2) Pub Date : 2023-07-05 Valentina Cinquina, Erik Keimpema, Daniela D. Pollak, Tibor Harkany
Obesity is a key medical challenge of our time. The increasing number of children born to overweight or obese women is alarming. During pregnancy, the circulation of the mother and her fetus interact to maintain the uninterrupted availability of essential nutrients for fetal organ development. In doing so, the mother's dietary preference determines the amount and composition of nutrients reaching the